title: Process versus outcome: the sugar window.
authors.affiliation: Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Aurora, Colo. Electronic address: david.fullerton@ucdenver.edu.
authors.forename: David A
authors.initials: DA
authors.lastname: Fullerton
authors.affiliation: Division of Cardiac Surgery, Massachusetts General Hospital, Boston, Mass.
authors.forename: Thoralf M
authors.initials: TM
authors.lastname: Sundt
mesh_terms: D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000191:economics / Q000592:standards; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D019983:Guideline Adherence; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000209:etiology; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D010043:Outcome and Process Assessment, Health Care / Q000191:economics / Q000592:standards; D017410:Practice Guidelines as Topic; D019984:Quality Indicators, Health Care; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin